Presentation TCTAP 2013

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Presenter: Adnan Kastrati

April 24, 2013

REGISTER for free or LOG IN to view this content

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Prevention

CAD Pharma

Clinical Pharma

Presentation

TCTAP 2013

Up Next

Presentation TCTAP 2013

Update of New TAVI Indications

Presenter: Thierry Lef?vre

April 25, 2013

More slides +

Presentation TVT 2013

Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve

Presenter: Petra Poliacikova

June 12, 2013

Presentation TVT 2013

Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates

Presenter: Mathew Williams

June 12, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.